Press release
Nasal Polyposis Market 2034: Epidemiology Trends, Innovative Therapies, Regulatory Approvals by DelveInsight | AstraZeneca, Amgen, Keymed Biosciences, GlaxoSmithKline, Sanofi, Regeneron Pharmaceuticals, Allakos Inc., Idorsia Pharmaceuticals Ltd., Optinose
To Know in detail about the Nasal Polyposis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Nasal Polyposis Market Forecast
https://www.delveinsight.com/sample-request/nasal-polyposis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Nasal Polyposis Market Report:
• The Nasal Polyposis market size was valued approximately USD 1,531 Million in the year 2021 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
• In January 2024, Upstream Bio has commenced the dosing of the initial participants in a Phase II clinical study of its monoclonal antibody, verekitug, targeting chronic rhinosinusitis with nasal polyps (CRSwNP). Verekitug, a primary program of the company, is a recombinant fully human immunoglobulin G1 monoclonal antibody designed to target the thymic stromal lymphopoietin receptor (TLSPR).
• In the 7MM, the United States reported the highest number of diagnosed cases of nasal polyposis, reaching approximately 22 million cases in 2023, with males accounting for 55% of these cases.
• One of the upcoming treatments for nasal polyposis, Fasenra (Benralizumab), is projected to achieve the largest market share by 2034 across the 7MM.
• In 2023, the total number of prevalent cases of Chronic Rhinosinusitis (CRS) across the 7MM was estimated at 70 million. There is an anticipated significant increase in these cases by the year 2034.
• In EU4 and the UK, Germany reported the highest number of diagnosed prevalent cases of nasal polyposis, totaling about 6 million cases, followed by the UK with around 4 million cases. Future projections suggest significant changes in these figures by 2034.
• Key Nasal Polyposis Companies: AstraZeneca, Amgen, Keymed Biosciences, GlaxoSmithKline, Sanofi, Regeneron Pharmaceuticals, Allakos Inc., Idorsia Pharmaceuticals Ltd., Optinose US Inc., Novartis, Keymed Biosciences Co.Ltd, Hoffmann-La Roche, Knopp Biosciences, and others
• Key Nasal Polyposis Therapies: FASENRA (benralizumab), Tezepelumab, CM310, GSK3511294 (depemokimab), Dupilumab, Mometasone furoate, AK001, ACT-774312, Fluticasone Propionate, OPN-375, Fevipiprant, CM310, Omalizumab, dexpramipexole, and others
• The Nasal Polyposis epidemiology based on gender analyzed that out of the total diagnosed prevalent cases of Nasal Polyposis in the EU-5 countries (Germany, France, Italy, Spain and the United Kingdom) about 60% were male
• The Nasal Polyposis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Nasal Polyposis pipeline products will significantly revolutionize the Nasal Polyposis market dynamics.
Nasal Polyposis Overview
Nasal polyposis, also known as chronic rhinosinusitis with nasal polyps (CRSwNP), is a condition characterized by the growth of benign, non-cancerous growths (polyps) inside the nasal passages and sinuses. These polyps are soft, painless swellings that result from chronic inflammation of the mucous membranes lining the nasal and sinus cavities.
Get a Free sample for the Nasal Polyposis Market Report -
https://www.delveinsight.com/report-store/nasal-polyposis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Nasal Polyposis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Nasal Polyposis Epidemiology Segmentation:
The Nasal Polyposis market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Nasal Polyposis
• Prevalent Cases of Nasal Polyposis by severity
• Gender-specific Prevalence of Nasal Polyposis
• Diagnosed Cases of Episodic and Chronic Nasal Polyposis
Download the report to understand which factors are driving Nasal Polyposis epidemiology trends @ Nasal Polyposis Epidemiology Forecast
https://www.delveinsight.com/sample-request/nasal-polyposis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Nasal Polyposis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Nasal Polyposis market or expected to get launched during the study period. The analysis covers Nasal Polyposis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Nasal Polyposis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Nasal Polyposis Therapies and Key Companies
• FASENRA (benralizumab): AstraZeneca
• Tezepelumab: AstraZeneca/ Amgen
• CM310: Keymed Biosciences
• GSK3511294 (depemokimab): GlaxoSmithKline
• Dupilumab: Sanofi
• Mometasone furoate: Regeneron Pharmaceuticals
• AK001: Allakos Inc.
• ACT-774312: Idorsia Pharmaceuticals Ltd.
• Fluticasone Propionate: Optinose US Inc.
• OPN-375: Optinose US Inc.
• Fevipiprant: Novartis
• CM310: Keymed Biosciences Co.Ltd
• Omalizumab: Hoffmann-La Roche
• dexpramipexole: Knopp Biosciences
Discover more about therapies set to grab major Nasal Polyposis market share @ Nasal Polyposis Treatment Market
https://www.delveinsight.com/sample-request/nasal-polyposis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Nasal Polyposis Market Drivers
• Approval of pipeline drugs in the forecasted period
• Rising prevalence
• Increased approvals from regulatory bodies
• Global exposure
Nasal Polyposis Market Barriers
• Nasal Polyposis Misdiagnosis
• Tools to define disease severity not defined well
• Lack of cost-effective treatment
• Lack of robust clinical pipeline
• Limited awareness on Nasal Polyposis
Scope of the Nasal Polyposis Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Nasal Polyposis Companies: AstraZeneca, Amgen, Keymed Biosciences, GlaxoSmithKline, Sanofi, Regeneron Pharmaceuticals, Allakos Inc., Idorsia Pharmaceuticals Ltd., Optinose US Inc., Novartis, Keymed Biosciences Co.Ltd, Hoffmann-La Roche, Knopp Biosciences, and others
• Key Nasal Polyposis Therapies: FASENRA (benralizumab), Tezepelumab, CM310, GSK3511294 (depemokimab), Dupilumab, Mometasone furoate, AK001, ACT-774312, Fluticasone Propionate, OPN-375, Fevipiprant, CM310, Omalizumab, dexpramipexole, and others
• Nasal Polyposis Therapeutic Assessment: Nasal Polyposis current marketed and Nasal Polyposis emerging therapies
• Nasal Polyposis Market Dynamics: Nasal Polyposis market drivers and Nasal Polyposis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Nasal Polyposis Unmet Needs, KOL's views, Analyst's views, Nasal Polyposis Market Access and Reimbursement
To know more about Nasal Polyposis companies working in the treatment market, visit @ Nasal Polyposis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/nasal-polyposis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Nasal Polyposis Market Report Introduction
2. Executive Summary for Nasal Polyposis
3. SWOT analysis of Nasal Polyposis
4. Nasal Polyposis Patient Share (%) Overview at a Glance
5. Nasal Polyposis Market Overview at a Glance
6. Nasal Polyposis Disease Background and Overview
7. Nasal Polyposis Epidemiology and Patient Population
8. Country-Specific Patient Population of Nasal Polyposis
9. Nasal Polyposis Current Treatment and Medical Practices
10. Nasal Polyposis Unmet Needs
11. Nasal Polyposis Emerging Therapies
12. Nasal Polyposis Market Outlook
13. Country-Wise Nasal Polyposis Market Analysis (2020-2034)
14. Nasal Polyposis Market Access and Reimbursement of Therapies
15. Nasal Polyposis Market Drivers
16. Nasal Polyposis Market Barriers
17. Nasal Polyposis Appendix
18. Nasal Polyposis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Nasal Polyposis Pipeline https://www.delveinsight.com/report-store/nasal-polyposis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Nasal Polyposis Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Nasal Polyposis market. A detailed picture of the Nasal Polyposis pipeline landscape is provided, which includes the disease overview and Nasal Polyposis treatment guidelines.
Nasal Polyposis Epidemiology https://www.delveinsight.com/report-store/nasal-polyposis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Nasal Polyposis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Nasal Polyposis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Orthopedic Trauma Devices Market https://www.delveinsight.com/report-store/orthopedic-trauma-devices-market
Global Orthopedic Trauma Devices Market was valued at USD 7.01 billion in 2023, growing at a CAGR of 6.43% during the forecast period from 2024 to 2030 to reach USD 10.15 billion by 2030. The demand for orthopedic trauma devices is witnessing growth due to the rising number of accident and trauma cases, growing prevalence of degenerative bone disorders, the rising number of sports-related injuries, rising demand for technologically advanced products, and increasing geriatric population are expected to drive product demand in the global orthopedic trauma devices market.
Acute Ischemic Stroke Market
https://www.delveinsight.com/report-store/acute-ischemic-stroke-ais-market
DelveInsight's 'Acute Ischemic Stroke Market Insights, Epidemiology, and Market Forecast - 2032' report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends of acute ischemic stroke in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Advanced Wound Care Market
https://www.delveinsight.com/report-store/advanced-wound-care-market
As per DelveInsight, the global Advanced Wound Care Market was valued at USD 10.44 billion in 2023, growing at a CAGR of 10.82% during the forecast period from 2024 to 2030, to reach USD 19.29 billion by 2030. The demand for advanced wound care is predominantly associated with the rising incidence of chronic wounds associated with various chronic disorders such as diabetes, and cancer, and also with the rising incidence of active wounds comprising burns, and surgical wounds, among others
Alcohol Use Disorder Market
https://www.delveinsight.com/report-store/alcohol-use-disorder-market
DelveInsight's "Alcohol Use Disorder (AUD) Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of AUD, historical and forecasted epidemiology, as well as the AUD market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market
https://www.delveinsight.com/report-store/chronic-inflammatory-demyelinating-polyneuropathy-cidp-market
DelveInsight's "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), historical and forecasted epidemiology as well as the Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Congestive Heart Failure Market
https://www.delveinsight.com/report-store/congestive-heart-failure-market
DelveInsight's "Congestive Heart Failure Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of CHF, historical and forecasted epidemiology as well as the CHF market trends in the United States, EU4 (Germany, France, Italy, Spain) and the United Kingdom, and Japan.
CDMO Market
https://www.delveinsight.com/report-store/contract-development-manufacturing-organization-market
Global CDMO market was valued at USD 100.02 billion in 2021, growing at a CAGR of 6.25% during the forecast period from 2024 to 2030, in order to reach USD 143.87 billion by 2030. Factors such as rising prevalence of various chronic and acute diseases leading to growing requirement of drugs, rising popularity of biologics as a treatment option are further expected to drive the demand for services offered by CDMOs as biologics being more complex than small molecules require elaborate facilities for product development.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nasal Polyposis Market 2034: Epidemiology Trends, Innovative Therapies, Regulatory Approvals by DelveInsight | AstraZeneca, Amgen, Keymed Biosciences, GlaxoSmithKline, Sanofi, Regeneron Pharmaceuticals, Allakos Inc., Idorsia Pharmaceuticals Ltd., Optinose here
News-ID: 3560735 • Views: …
More Releases from DelveInsight Business Research
Von Willebrand Disease Market Insights Highlight Expanding Outlook Till 2034, De …
DelveInsight's "Von Willebrand Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Von Willebrand Disease, historical and forecasted epidemiology as well as the Von Willebrand Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Von Willebrand Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Von Willebrand Disease…
Global Artificial Kidney Market to reach USD 6.09 billion by 2032 at a CAGR of 1 …
According to DelveInsight's analysis, The growing demand for artificial kidneys is primarily fueled by the increasing prevalence of kidney failure and end-stage renal disease (ESRD), alongside a rising incidence of contributing factors such as diabetes, hypertension, and an aging global population. These trends are driving the need for advanced and efficient renal care technologies. Moreover, the expanding preference for home-based dialysis solutions, combined with continuous technological innovations and frequent product…
Global Bladder Scanners Market to grow at a CAGR of 6.12% by 2032, Evaluates Del …
According to DelveInsight's analysis, The growing prevalence of urinary disorders such as incontinence, urinary retention, and overactive bladder especially among the aging population continues to drive demand for bladder scanners. The increasing preference for non-invasive and efficient diagnostic tools is further propelling market growth, as bladder scanners provide a safe, quick, and accurate alternative to traditional catheterization. Their expanding use across hospitals, clinics, and home care settings highlights their clinical…
Global Transdermal Drug Delivery Devices Market to reach USD 121,798.76 million …
According to DelveInsight's analysis, The rising incidence of chronic diseases, along with the growing adoption of advanced third-generation transdermal drug delivery systems, is substantially driving the global market's growth.
DelveInsight's "Transdermal Drug Delivery Devices Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Transdermal Drug Delivery Devices…
More Releases for Nasal
External Nasal Dilator and Nasal Strip Research:CAGR of 5.9% during the forecast …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "External Nasal Dilator and Nasal Strip- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the…
Nasal Polyposis Market 2034 | Nasal Polyposis Therapies, Clinical trials, Nasal …
As per DelveInsight, the Nasal Polyposis Market is anticipated to grow immensely in the coming years owing to the launch of upcoming therapies and the increase in the incident population of Nasal Polyposis in the 7MM.
DelveInsight's "Nasal Polyposis Market Insights, Epidemiology, and Market Forecast 2034 [https://www.delveinsight.com/report-store/nasal-polyposis-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Nasal Polyposis market size, share, trends, and growth…
External Nasal Dilator and Nasal Strip Market Size, Players, Revenue Analysis 20 …
External Nasal Dilator and Nasal Strip Market Overview 2023:
The External Nasal Dilator and Nasal Strip Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the External Nasal Dilator and Nasal Strip market. This report…
Nasal Drug Delivery Market - Effortless Delivery, Optimal Results: Nasal Drug De …
Newark, New Castle, USA - new report, titled Nasal Drug Delivery Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Nasal Drug Delivery market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Nasal Drug Delivery market. The report offers an overview of…
Nasal Aspirators Market: Effective Solutions for Infant Nasal Congestion | Smith …
Allied Market Research Analyst have added a new research study on Title Nasal Aspirators Market, Global Outlook and Forecast 2023-2030 with detailed information & Key Players Such as B. Braun Melsungen, A. Titan Instruments, Altay Scientific Group, Neilmed Pharmaceuticals, Smith & Nephew, Koninklijke Philips, B.Well Swiss AG, KLS Martin Group, ResMed, and Avita Medical. The Study provides in-depth comprehensive analysis includes Clear Market definitions, classifications, manufacturing processes, cost structures, development…
Nasal Care Device Market Promoting Nasal Health and Hygiene with Innovative Devi …
Global Nasal Care Device Market Overview:
The Nasal Care Device market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Nasal Care Device market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and globalization. This growth…
